Blis Technology stock jumped 50% on news of wider rollout through Sinopharm

Blis Technology stock jumped 50% on news of wider rollout through Sinopharm
By Jonathan Underhill Aug. 25 (BusinessDesk) - Blis Technologies shares soared 50 percent after the biotech company said its Chinese partner planned to roll out a much wider market test of its probiotic products for mouth and throat health than it had initially indicated. The shares jumped 1 cent to 3 cents on the NZX, the highest since November last year, valuing the company at $33 million. The company said that following a test market trial through Sinopharm, the largest oral health and pharmaceutical company in China, its Chinese pa...